STONY BROOK, N.Y. - May 13, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the three and six months ended March 31, 2021. “We are pleased to deliver a strong fiscal second quarter with [...]
STONY BROOK, N.Y. May 13, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), today clarifies the scope of its newly authorized asymptomatic serial screening indication for its Linea COVID-19 Assay Kit (the “Assay Kit”) and certain information contained in its previously disseminated 12 May 2021 press release (the “Press [...]
STONY BROOK, N.Y. May 12, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s Linea™ COVID-19 Assay Kit (the “Assay [...]
STONY BROOK, N.Y. May 11, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Applied DNA Clinical Labs, LLC (ADCL) subsidiary received CLIA (Clinical Laboratory Improvement Amendments) certification from the New York State Department of [...]
Applied DNA Sciences and and TruTrace Technologies team up to tag, test, and track cannabis products from seed to sale. Stephanie Neil |May 10th, 2021 Tracking cannabis from the farm to the dispensary is important to the safety of the entire marketplace. How to do it, however, has left [...]
More than ever, apparel brands are tasked with adapting to a global environment that they have no control over. With higher sustainability standards among consumers and growing ethical concerns about textile origins, brands can no longer remain ignorant to the nature of the raw materials they are sourcing. Raw material provenance, in particular, became a [...]
STONY BROOK, N.Y. – May 7, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it will report fiscal 2021 second quarter financial results after market close on Thursday, May 13, 2021. The Company’s management will [...]
STONY BROOK, N.Y. – May 7, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it will report fiscal 2021 second quarter financial results after market close on Thursday, May 13, 2021. The Company’s management will discuss the [...]
STONY BROOK, N.Y. & ROME. May 6, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. (“Evvivax”), today announced a booster injection delivered 30 days after the prime vaccination elicited an [...]